WORLD-SURF-LEAGUE
Today the World Surf League and Corona announced a multi-year partnership agreement through 2018, making Corona the Official Beer of the World Surf League globally, with the exception of the U.S. market.
“2015 was the single biggest year in surfing history across every major metric we measure, and we are thrilled that Corona – one of the Top 10 most valuable beer brands in the world according to BrandZ 2015 – has chosen to partner with us,” said Mark Noonan, Global Chief Commercial Officer of the World Surf League. “Corona’s aspirational lifestyle is a perfect complement to the WSL, and we are extremely proud to have them join our group of world class partners.”
The WSL and Corona will work together on consumer and customer activations in all key markets aligning Corona’s authentic and unpretentious lifestyle with the World Surf League’s mission of putting the world’s best surfers on the world’s best waves. Corona will engage surf fans through compelling original content, exciting on-site activations like the Corona Sunsets festivals, and corporate social responsibility initiatives at some of the most exotic and remote locations on the planet.
“Corona has been popular with surfers since the early 1980s, when surfers first discovered the point breaks of Baja and regularly enjoyed a crisp, refreshing Corona after catching the waves. We see The World Surf League as a great ambassador for our brand and the Corona lifestyle,” said Global VP Corona Marcel Marcondes. “Corona reminds us all to take a step back, reconnect to our essential nature and enjoy moments outside. This partnership with the WSL creates an abundance of such special moments in the most beautiful settings all year long. We believe the WSL provides us with a valuable opportunity to connect with the WSL’s growing community and LDA fans that are inspired by the surf lifestyle.”
Corona will partner with WSL Championship Tour surfers Coco Ho, Alejo Muniz, Matt Wilkinson and Julian Wilson. At each stop of the WSL Championship Tour, Corona will help ensure the experience of fans is unforgettable. Key markets for brand activations in 2016 will include Australia, Brazil, South Africa and France.
The 2016 Samsung Galaxy World Championship Tour begins with the Quiksilver Pro in Australia, kicking-off on March 10. Fans can catch all the live action by going to worldsurfleague.com or by downloading the free app in either the iTunes store or Google Play.
About The World Surf League
The World Surf League (WSL), formerly the Association of Surfing Professionals (ASP), is dedicated to celebrating the world’s best surfing on the world’s best waves through a variety of best-in-class audience platforms. The League, headquartered in Santa Monica, is a truly global sport with regional offices in Australasia, Africa, North America, South America, Hawaii, Japan and Europe.
The WSL has been championing the world's best surfing since 1976, running global events across the Samsung Galaxy Men's and Women's Championship Tours, the Big Wave Tour, Qualifying Series, Junior and Longboard Championships, as well as the WSL Big Wave Awards. The League possesses a deep appreciation for the sport's rich heritage while promoting progression, innovation and performance at the highest levels.
Showcasing the world's best surfing on its digital platform at WorldSurfLeague.com as well as the free WSL app, the WSL has a passionate global fan base with millions tuning in to see world-class athletes like Mick Fanning, John John Florence, Stephanie Gilmore, Greg Long, Gabriel Medina, Carissa Moore, Makua Rothman, Kelly Slater, Adriano de Souza and more battle on the most unpredictable and dynamic field of play of any sport in the world.
For more information, please visit WorldSurfLeague.com .
About Corona
Corona is the leading beer brand in Mexico, the 6th most valuable beer brand in the world*, and the most popular Mexican beer worldwide, with sales in more than 120 countries. Corona Extra was first brewed in 1925 at the Cervecería Modelo in Mexico City. Ten years after its launch, Corona became the best-selling beer in Mexico, and today continues to stand for Mexican pride around the world. Follow global Corona on Instagram: @corona
View source version on businesswire.com: http://www.businesswire.com/news/home/20160309006234/en/
Contact:
World Surf League
Patty Smith, 310-804-2721
psmith@worldsurfleague.com
or
Corona
Karen
Couck
karencouck@ab-inbev.com
or
Kathleen
Van Boxelaer
kathleen.vanboxelaer@ab-inbev.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Altris and Draslovka Partner to Scale Europe’s First Sodium-Ion Battery Technology Supply Chain15.1.2026 14:00:00 CET | Press release
Altris, a Swedish sodium-ion battery developer, and Draslovka, a global leader in specialty chemicals, have entered a strategic partnership to build Europe’s first industrial-scale sodium-ion cathode value chain. Under the comprehensive agreement that includes a total 19.3 MEUR in-kind investment by Draslovka in Altris, the two companies will scale fully connected production of Altris’ patented sodium-ion cathode active material (CAM) at Draslovka’s facility in Kolín, Czech Republic, supplying up to 350 tonnes of CAM annually. Draslovka and Altris are partnering to convert an existing line at Draslovka’s Kolín facility for production of Altris’ sodium-ion CAM, enabling rapid time-to-market and capital-efficient scale-up. Once ramped, the line will support production of up to 350 tonnes annually – a European-controlled supply equivalent to around 175 MWh of sodium-ion cell capacity. As part of the agreement, Draslovka is making a new in‑kind 19.3 MEUR strategic investment in Altris to c
CPP Investments Increases Commitment to Canadian Market through Northleaf Capital Partners15.1.2026 14:00:00 CET | Press release
Canada Pension Plan Investment Board (CPP Investments) and Northleaf Capital Partners (Northleaf) today announced a significant expansion of their longstanding Canadian investment partnership, supporting the growth and scaling of domestic private companies. CPP Investments has committed to invest an additional C$750 million through its established Canadian mid-market program managed by Northleaf, bringing CPP Investments’ cumulative commitments to the manager to more than C$3 billion since inception. The customized mandate focuses on maximizing net returns through a diversified strategy that includes primary fund commitments to small and mid-market Canadian buyout funds, secondary investments, and direct co-investments focused on the domestic market. “There are compelling investment opportunities in the Canadian market, and our two-decade long partnership with Northleaf has proven to be an effective and scalable way to invest in homegrown businesses with patient, long-term capital,” sa
Vantage Data Centers Completes £200M Tap of Existing £600M Industry-First EMEA Data Center Asset-Backed Securitization (ABS) and Adds New £54M Class B Tranche15.1.2026 14:00:00 CET | Press release
Financing will support the company’s expansion across EMEA to keep pace with AI and cloud demand Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced it has raised an additional £254 million in securitized term notes. £200 million was raised through a tap of the existing Class A-2 Notes while £54 million was raised from the new Class B Tranche. This builds on Vantage’s debut public issuance in 2024 raising £600 million, which was the first-ever EMEA data center ABS completed in sterling. The Class A-2 Notes are rated A-, A (low) and A by Standard & Poor’s, Morningstar DBRS and Scope Ratings, respectively. The Class B Notes are rated BBB- by Standard & Poor’s and BBB by Morningstar DBRS and Scope Ratings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115777091/en/ Vantage’s 148MW Cardiff, Wales, campus is one of Europe’s largest hyperscale data center campuses. The new notes
QPS Selects Oracle Argus Safety Database to Enhance Pharmacovigilance in Clinical Trials15.1.2026 13:57:00 CET | Press release
QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier pharmacovigilance system designed to support comprehensive safety case management for clinical trials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115711485/en/ Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC. The adoption of the Oracle Argus drug safety platform underscores QPS’s commitment to advancing patient safety, regulatory compliance, and operational excellence across its clients’ clinical drug development programs. Integrating this industry-standard safety platform strengthens QPS’ ability to capture, manage, and report adverse events in accordance with global regulatory requirements. “Ensuring patient safety and data integrity is at the heart of what we do when conducting clinical trials,” said Dere
InterAx and Alveus Announce Strategic Research and Licensing Agreement to Develop Differentiated Therapeutic Candidate for Metabolic Disease15.1.2026 13:30:00 CET | Press release
InterAx Biotech Ltd (“InterAx”) and Alveus Therapeutics Inc. (“Alveus”) today announced a strategic research collaboration and licensing agreement to develop a differentiated small molecule candidate for metabolic disease to deliver durable weight loss with superior tolerability. This partnership forms a joint research effort on a target and modality of established but untapped therapeutic interest by combining InterAx’s Deep Signal™ discovery platform – designed to optimize candidates toward superior signaling profiles – with Alveus’s deep R&D expertise and leadership in obesity, diabetes, and cardiometabolic disease. While financial terms remain undisclosed, the agreement includes an upfront payment and eligibility for future development, regulatory, and commercial milestones. “We are thrilled to join forces with Alveus to advance a highly differentiated therapeutic candidate designed to overcome the limitations of today’s obesity medications,” said Andrew Roberts, CEO of InterAx. “O
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom